- Retrophin (RTRX) appoints Stephen Aselage President and COO effective immediately. He will be responsible for corporate development activities including the commercialization of current products, building out the firm's global infrastructure and exploring new business development opportunities.
- Mr. Aselage joined Retrophin in 2012 from BioMarin Pharmaceuticals where he was EVP and Chief Business Officer.
Leadership change at Retrophin
Recommended For You
More Trending News
About TVTX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TVTX | - | - |
| Travere Therapeutics, Inc. | ||